ReviewCancers2021

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells.

Kate J Dixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.